ArticleJournal of medical imaging (Bellingham, Wash.)2025
Harnessing chemically crosslinked microbubble clusters using deep learning for ultrasound contrast imaging.
Article in Journal of medical imaging (Bellingham, Wash.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Super-resolution contrast-enhanced ultrasound: recent advances.Ultrasonography (Seoul, Korea) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Purpose: We aim to investigate and isolate the distinctive acoustic properties generated by chemically crosslinked microbubble clusters (CCMCs) using machine learning (ML) techniques, specifically using an anomaly detection model based on autoencoders. Approach: CCMCs were synthesized via copper-free click chemistry and subjected to acoustic analysis using a clinical transducer. Radiofrequency data were acquired, processed, and organized into training and testing datasets for the ML models. We trained an anomaly detection model with the nonclustered microbubbles (MBs) and tested the model on the CCMCs to isolate the unique acoustics. We also had a separate set of control experiments that was performed to validate the anomaly detection model. Results: The anomaly detection model successfully identified frames exhibiting unique acoustic signatures associated with CCMCs. Frequency domain analysis further confirmed that these frames displayed higher amplitude and energy, suggesting the occurrence of potential coalescence events. The specificity of the model was validated through control experiments, in which both groups contained only individual MBs without clustering. As anticipated, no anomalies were detected in this control dataset, reinforcing the model's ability to distinguish clustered MBs from nonclustered ones. Conclusions: We highlight the feasibility of detecting and distinguishing the unique acoustic characteristics of CCMCs, thereby improving the detectability and localization of contrast agents in ultrasound imaging. The elevated acoustic amplitudes produced by CCMCs offer potential advantages for more effective contrast agent detection, which is particularly valuable in super-resolution ultrasound imaging. Both the contrast agent and the ML-based analysis approach hold promise for a wide range of applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.